Commentary on McDonald et al. (2018): Intranasal naloxone-from the laboratory to the real world

Suzanne Nielsen^{1

2}, Sarah Larney¹, Michael Farrell¹

Affiliations

¹ National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.
² South Eastern Sydney Local Health District Drug and Alcohol Services, Surry Hills, NSW, Australia.

Comment

Suzanne Nielsen et al. Addiction. 2018 Mar.

. 2018 Mar;113(3):494-495.

doi: 10.1111/add.14087.

Suzanne Nielsen^{1

2}, Sarah Larney¹, Michael Farrell¹

¹ National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.
² South Eastern Sydney Local Health District Drug and Alcohol Services, Surry Hills, NSW, Australia.

No abstract available

Keywords: Bioavailability; intranasal; naloxone; opioid overdose; opioid related-mortality; pharmacokinetics.

Comment on

Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: Phase I healthy volunteer study.
McDonald R, Lorch U, Woodward J, Bosse B, Dooner H, Mundin G, Smith K, Strang J. McDonald R, et al. Addiction. 2018 Mar;113(3):484-493. doi: 10.1111/add.14033. Epub 2017 Nov 16. Addiction. 2018. PMID: 29143400 Free PMC article. Clinical Trial.